Opioid Tolerance and Urine Drug Testing among Initiates of Extended-Release or Long-Acting Opioids in Food and Drug Administration's Sentinel System

Project Title Opioid Tolerance and Urine Drug Testing among Initiates of Extended-Release or Long-Acting Opioids in Food and Drug Administration's Sentinel System
Date
Monday, November 20, 2017
Location
Description

A risk evaluation and mitigation strategy for extended-release and long-acting (ER/LA) opioid analgesics was approved by the Food and Drug Administration in 2012. The authors' objective was to assess frequency of opioid tolerance and urine drug testing for individuals initiating ER/LA opioid analgesics.

Medical Product
extended-release and long-acting (ER/LA) opioid analgesic
opioid
Population / Cohort
All individuals 0-64 years of age
Time Period
January 1, 2009 – December 31, 2013
Authors

Marc R. Larochelle MD, MPH; Noelle M. Cocoros DSc, MPH; Jennifer Popovic DVM, MA; Elizabeth C. Dee MPH; Cynthia Kornegay PhD; Jing Ju PharmD, PhD; Judith A. Racoosin MD, MPH

Data Sources
Mini-Sentinel Distributed Database (MSDD)
Related Links